CompletedNot Applicable

A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE

Italy250 participantsStarted 2015-11-01

Plain-language summary

This study aims to investigate the efficacy of Guided Written Disclosure Protocol (GWDP) in promoting post-traumatic growth through a process of meaning reconstruction in cancer patients at the end of chemotherapy. Also, the intervention (GWDP) intends to reduce distress symptoms (i.e. intrusive thoughts, avoidance, depression and anxiety).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. A histologically-confirmed stage I-III breast or colon cancer
✓. Adjuvant chemotherapy completed by no more than eight months
✓. Disease free (no evidence of metastatic disease) according to what reported by the oncologist during the follow-up oncological consultation
✓. Aged 18 years or over
✓. Property of written and spoken Italian language

Exclusion criteria

✕. Having received a structured psychological intervention performed by a psychologist or by a psychiatrist, for at least six months during the last three years
✕. Having received a psychopharmacological treatment for a codified psychiatric disorder (according to the DSM-V) during the last three years

What they're measuring

Change in post-traumatic growth from baseline to post-intervention assessment and at 6 months follow-up. Post-Traumatic Growth Inventory (PTGI) will be used to assess this outcome

Timeframe: Baseline (T0): before randomization. Post-intervention (T1): three months (plus or minus 15 days) from (T1). Follow-up (T2): six months after T1.

Trial details

NCT IDNCT02824484

SponsorAzienda USL Reggio Emilia - IRCCS

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2019-11-18

View on ClinicalTrials.gov More Breast Cancer trials